PonteMed AG continuously working for innovation in health care
and human wellbeing.
Welcome to PonteMed AG

PRODUCTS

PRODUCTS

PELVIPOWER - POWER FROM THE CORE

Problem
Pelvic health issues affect one in 15 people worldwide yet current treatment procedures remain invasive or unreliable.
Around the world suffer 200 million people suffer from incontinence and vitality deficits in the middle of the body.
Previous therapies mainly concern pharmaceutical products, diapers and pads in various forms, surgical interventions and invasive treatments.

Solution
A new patented method of treatment that trains your pelvic floor and the surrounding muscles purposefully and effectively without invasive medical procedures.

State-of-the-art medical technology with targeted support for individual training.
Combines magnetic field therapy with biofeedback training methods; CE Medical certified.
Completely non-invasive procedure with no disruption of patient everyday activities.

Market
Incontinence Retail (total addressable market): 9 Bi USD growing with 8% p.a.
Incontinence Service (total addressable market): 1 Bi USD
Current pelvic treatment providers:
1.8 M physicians in the EU
550,000 Physiotherapists in the EU
New since 2020 – the Pelvipower Sport concept for the global market

MIAVIA - HEALTH&BEAUTY

Problem
There are innumerable many providers of physiotherapy, wellness as well as cosmetics and beauty services.
The market is almost atomized, customers can hardly get an overview.
Holistic offers are rare and even rarer centrally located, in city centers.

Solution
The MiaVia concept includes small health centers in good frequency locations in larger city centers.
The approach of MiaVia is holistic – combining physiotherapy, wellness, cosmetics and beauty under one roof.
Additionally, this is an ideal service and marketing gateway for PonteMed to bring device developments quickly to the end customers and multiplies.
It ́s also a short way back from the clients to R&D for feedbacks and amendments.
Market
Global Wellness Economy Market: $4.5 Trillion market
Preventive & Personalized Medicine and Public Health: $575 Billion market
Personal Care, Beauty & Anti-Aging: $1,083 Billion market
Healthy Eating, Nutrition & Weight Loss: $702 Billion market

VALEIA - POWER TO BREATHE

Problem
It has not yet technologically been possible to use magnetic stimulation for specific small target body regions.
Many types of invasive methods have to be replaced by non-invasive stimulation.
Intensive care ventilation leads to long-term damage to the lungs caused by positive pressure and to „critical illness polyneuropathy“. Patients suffer from a diffuse, symmetrical respiratory muscle weakness.

Solution
Valeia eliminates the risk of infection through percutaneous diaphragm pacing for partial or complete respiratory ventilation.
Valeia ́s therapeutic approach is based on transcutaneous neuromuscular electrical stimulation of the respiratory muscles during ventilation. Valeia shortens the weaning period after intensive care ventilation.
PonteMed has acquired the patents from the Medical University of Vienna and has already successfully registered for international protection. One patent is for focused stimulation, the other for safety monitoring.
In the next step, this invention – named Valeia – will be developed into a marketable product.

Market
Europe owns in average 11.5 ICUs per 100,000 inhabitants (2012), what leads to a total number of approx. 85,000 ICUs.
North America owns approx. 90,000 ICUs (2019) and the rest of the world is estimated with additional 200,000 units.
During Corona crisis the number of ICUs increased dramatically.
Most of these ICUs are equipped with ventilation devices.

PELVIPOWER - POWER FROM THE CORE

Problem
Pelvic health issues affect one in 15 people worldwide yet current treatment procedures remain invasive or unreliable.
Around the world suffer 200 million people suffer from incontinence and vitality deficits in the middle of the body.
Previous therapies mainly concern pharmaceutical products, diapers and pads in various forms, surgical interventions and invasive treatments.

Solution
A new patented method of treatment that trains your pelvic floor and the surrounding muscles purposefully and effectively without invasive medical procedures.

State-of-the-art medical technology with targeted support for individual training.
Combines magnetic field therapy with biofeedback training methods; CE Medical certified.
Completely non-invasive procedure with no disruption of patient everyday activities.

Market
Incontinence Retail (total addressable market): 9 Bi USD growing with 8% p.a.
Incontinence Service (total addressable market): 1 Bi USD
Current pelvic treatment providers:
1.8 M physicians in the EU
550,000 Physiotherapists in the EU
New since 2020 – the Pelvipower Sport concept for the global market

MIAVIA - HEALTH&BEAUTY

Problem
There are innumerable many providers of physiotherapy, wellness as well as cosmetics and beauty services.
The market is almost atomized, customers can hardly get an overview.
Holistic offers are rare and even rarer centrally located, in city centers.

Solution
The MiaVia concept includes small health centers in good frequency locations in larger city centers.
The approach of MiaVia is holistic – combining physiotherapy, wellness, cosmetics and beauty under one roof.
Additionally, this is an ideal service and marketing gateway for PonteMed to bring device developments quickly to the end customers and multiplies.
It ́s also a short way back from the clients to R&D for feedbacks and amendments.
Market
Global Wellness Economy Market: $4.5 Trillion market
Preventive & Personalized Medicine and Public Health: $575 Billion market
Personal Care, Beauty & Anti-Aging: $1,083 Billion market
Healthy Eating, Nutrition & Weight Loss: $702 Billion market

VALEIA - POWER TO BREATHE

Problem
It has not yet technologically been possible to use magnetic stimulation for specific small target body regions.
Many types of invasive methods have to be replaced by non-invasive stimulation.
Intensive care ventilation leads to long-term damage to the lungs caused by positive pressure and to „critical illness polyneuropathy“. Patients suffer from a diffuse, symmetrical respiratory muscle weakness.

Solution
Valeia eliminates the risk of infection through percutaneous diaphragm pacing for partial or complete respiratory ventilation.
Valeia ́s therapeutic approach is based on transcutaneous neuromuscular electrical stimulation of the respiratory muscles during ventilation. Valeia shortens the weaning period after intensive care ventilation.
PonteMed has acquired the patents from the Medical University of Vienna and has already successfully registered for international protection. One patent is for focused stimulation, the other for safety monitoring.
In the next step, this invention – named Valeia – will be developed into a marketable product.

Market
Europe owns in average 11.5 ICUs per 100,000 inhabitants (2012), what leads to a total number of approx. 85,000 ICUs.
North America owns approx. 90,000 ICUs (2019) and the rest of the world is estimated with additional 200,000 units.
During Corona crisis the number of ICUs increased dramatically.
Most of these ICUs are equipped with ventilation devices.